Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
Main Authors: | Xu-Sheng Liu, Lu-Meng Zhou, Ling-Ling Yuan, Yan Gao, Xue-Yan Kui, Xiao-Yu Liu, Zhi-Jun Pei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.751004/full |
Similar Items
-
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
by: Xu-Sheng Liu, et al.
Published: (2021-07-01) -
Pan-cancer analysis of the prognostic and immunological role of nucleophosmin/nucleoplasmin 3 (NPM3) and its potential significance in lung adenocarcinoma
by: Qianhui Wei, et al.
Published: (2023-10-01) -
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma
by: Yao-Hua Zhang, et al.
Published: (2022-10-01) -
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association
by: Xu-Sheng Liu, et al.
Published: (2024-02-01) -
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
by: Chen Huo, et al.
Published: (2021-07-01)